5801 - 5810 of 8808 Results
Title
Year
-
OPENTitle: Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 33Issue #:Start Page: 107End Page: 114Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.09.025Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5154808Citation Count: 24
-
OPENTitle: Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 33Issue #:Start Page: 127End Page: 133Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.10.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6091572Citation Count: 10
-
OPENTitle: The R1441C-Lrrk2 mutation induces myeloid immune cell exhaustion in an age- and sex-dependent manner in miceJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 16Issue #: 772Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adl1535Best OA location URL: https://www.science.org/doi/pdf/10.1126/scitranslmed.adl1535?download=trueCitation Count: 5
-
OPENTitle: Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegenerationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 382Issue #:Start Page: 114959End Page: 114959Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2024.114959Best OA location URL: https://doi.org/10.1016/j.expneurol.2024.114959Citation Count: 4
-
OPENTitle: Blood‐based multivariate methylation risk score for cognitive impairment and dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 10Start Page: 6682End Page: 6698Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14061Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14061Citation Count: 11
-
OPENTitle: Exposure to household pesticides and Parkinson's disease in the Parkinson's Progression Markers Initiative cohortJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2024.1411468Best OA location URL: https://doi.org/10.3389/fneur.2024.1411468Citation Count: 2
-
OPENTitle: PINK1 is a target of T cell responses in Parkinson’s diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci180478Best OA location URL: http://www.jci.org/articles/view/180478/files/pdfCitation Count: 7
-
OPENTitle: Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samplesJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci183592Best OA location URL: http://www.jci.org/articles/view/183592/files/pdfCitation Count: 2
-
OPENTitle: Replication and reliability of Parkinson's disease clinical subtypesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 124Issue #:Start Page: 107016End Page: 107016Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107016Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11590651Citation Count: 1
-
RESTRICTEDTitle: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neuronsJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00779-9Best OA location URL: https://doi.org/10.1186/s13024-024-00779-9Citation Count: 9